Omalizumab Subcutaneous and Parathyroid hormone Subcutaneous
Determining the interaction of Omalizumab Subcutaneous and Parathyroid hormone Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: parathyroid hormone
Brand name: Natpara
Synonyms: Parathyroid hormone, Parathyroid Hormone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Parcopa
- Omalizumab Subcutaneous-Paregoric
- Omalizumab Subcutaneous-Paremyd
- Omalizumab Subcutaneous-Paremyd Ophthalmic
- Omalizumab Subcutaneous-Paricalcitol
- Omalizumab Subcutaneous-Paricalcitol Capsules
- Parathyroid hormone Subcutaneous-Ombitasvir, Paritaprevir, and Ritonavir
- Parathyroid hormone Subcutaneous-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Parathyroid hormone Subcutaneous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Parathyroid hormone Subcutaneous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Parathyroid hormone Subcutaneous-Omeclamox-Pak
- Parathyroid hormone Subcutaneous-Omega-3 Fatty Acid Capsules